GlassScriptPhysician profile
Lauren Matla
NPI 1710596754
$1,585.57
in general payments reported to CMS, 2019-2025
14 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.89 · 2022: $444 · 2023: $374 · 2024: $532 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $844.89 | 2022-2025 | Ostene, Floseal, Tisseel |
| Mimedx Group, INC. | $170.50 | 2024 | |
| Boston Scientific Corporation | $141.38 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $111.58 | 2024 | Inpefa |
| Getinge USA Sales, LLC | $56.51 | 2025 | Vasoview Hemopro 2 |
| Edwards Lifesciences Corporation | $50.83 | 2025 | Inspiris Resilia Aortic Valve |
| Novartis Pharmaceuticals Corporation | $39.26 | 2024 | |
| Atricure, INC. | $37.57 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Kci USA, INC. | $32.91 | 2022 | |
| Solventum Corporation | $26.50 | 2024 | Prevena, V.A.C. Veraflo |
| Abbott Laboratories | $21.74 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Terumo Cardiovascular Systems Corporation | $18.99 | 2024 | Virtuosaph Plus With Radial Indication |
| Molnlycke Health Care US, LLC | $18.02 | 2022 | |
| Alexion Pharmaceuticals, INC. | $14.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Matla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.